Update on Diffuse Large B-Cell Lymphoma for Newly Diagnosed Patients – November 14, 2024

Webinars

The Lymphoma Research Foundation’s free webinars are hour-long interactive programs led by leading lymphoma experts who discuss lymphoma, treatment options, clinical trials, and promising innovative research. Webinars can be listened to live on the telephone or via web streaming.

Update on Diffuse Large B-Cell Lymphoma for Newly Diagosed Patients

DATE: Thursday, November 14, 2024
TIME: 2:00 PM – 3:00 PM Eastern Time

VIRTUAL PROGRAM – This is a Zoom virtual event, accessible online and over the phone. Access instructions will be emailed after registration. If you are new to Zoom, learn more here: How-Do-I-Join-or-Test-My-Computer-Audio. Note: Look for Zoom as sender of confirmation and reminder emails.

Featuring

Matthew Lunning, DO, FACP
Hematologist and Oncologist
Assistant Vice Chancellor of Clinical Research
Associate Vice Chair of Research, Department of Internal Medicine
Associate Professor, Division of Oncology & Hematology
University of Nebraska

Program Overview

  • Overview of Diffuse Large B-Cell Lymphoma (DLBCL)
  • Current Treatment Options
  • New and Emerging Treatment Approaches
  • Clinical Trial Updates
  • Question and Answers

Ways to Register

VIRTUAL PROGRAM – This is a Zoom virtual event, accessible online and over the phone. Access instructions will be emailed after registration. If you are new to Zoom, learn more here: How-Do-I-Join-or-Test-My-Computer-Audio. Note: Zoom will email a confirmation and reminder.

Call: 800-500-9976
Email: helpline@lymphoma.org

This program is for patients and survivors, caregivers and program supporters. If you are a pharmaceutical industry professional that is interested in attending but your company is not listed as a sponsor, please email vgonzalez@lymphoma.org to learn more about sponsorship.

Disclaimer: The Lymphoma Research Foundation is a national nonprofit organization based in the United States with educational programs and resources are intended for a US-based audience. These program and resources address available lymphoma treatments in the United States. and information on drug approvals by the US Food and Drug Administration.

For individuals outside of the US, we recommend the Lymphoma Coalition at www.lymphomacoalition.org. The Lymphoma Coalition is a global network of worldwide nonprofit/NGO lymphoma patient organizations with information appropriate for non US-based audiences.

Program Supporters

This program is supported through unrestricted educational grants from: